{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:25:32Z","timestamp":1790137532614,"version":"4.0.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":1533,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["FDA"],"award-info":[{"award-number":["FDA"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010951","name":"Drainage Services Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008676","name":"CMC Microsystems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004354","name":"Svensk K\u00e4rnbr\u00e4nslehantering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009720","name":"Jerold B. Katz Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jpain.2018.12.003","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T12:19:12Z","timestamp":1545221952000},"page":"746-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["AAAPT Diagnostic Criteria for Acute Sickle Cell Disease Pain"],"prefix":"10.1016","volume":"20","author":[{"given":"Joshua J.","family":"Field","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1466","authenticated-orcid":false,"given":"Samir K.","family":"Ballas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5420-4207","authenticated-orcid":false,"given":"Claudia M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori E.","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlton","family":"Dampier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika S.","family":"Darbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna K.","family":"McClish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wally R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Zempsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2018.12.003_bib0001","first-page":"507","article-title":"L-Glutamine approved for use in patients with sickle cell disease","volume":"68","author":"Ali","year":"2018","journal-title":"J Pakistan Med Assoc"},{"key":"10.1016\/j.jpain.2018.12.003_bib0002","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2141.2005.05834.x","article-title":"Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants","volume":"132","author":"Amer","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0003","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1547-5069.2010.01376.x","article-title":"Emerging biobehavioral factors of fatigue in sickle cell disease","volume":"43","author":"Ameringer","year":"2011","journal-title":"J Nurs Scholarsh"},{"key":"10.1016\/j.jpain.2018.12.003_bib0004","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/MPH.0000000000000431","article-title":"Fatigue in children with sickle cell disease: Association with neurocognitive and social-emotional functioning and quality of life","volume":"37","author":"Anderson","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0005","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1002\/ajh.24718","article-title":"Beyond the transition of adolescents and young adults with sickle cell disease to adult care: Role of geography","volume":"92","author":"Anderson","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0006","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/adc.67.4.517","article-title":"Fetal haemoglobin and early manifestations of homozygous sickle cell disease","volume":"67","author":"Bailey","year":"1992","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpain.2018.12.003_bib0007","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3476(85)80230-4","article-title":"Clinical presentation of homozygous sickle cell disease","volume":"106","author":"Bainbridge","year":"1985","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpain.2018.12.003_bib0008","unstructured":"Ballas SK: Chapter 15: Obstetrics, Gynecology, and Sickle Cell Pain. In: Sickle Cell Pain, 2nd Edition, International Association for the Study of Pain, Washington DC, 2014, pp. 499--520."},{"key":"10.1016\/j.jpain.2018.12.003_bib0009","unstructured":"Ballas SK: Sickle Cell Pain, 2nd Edition, International Association for the Study of Pain, Washington DC, 2014."},{"key":"10.1016\/j.jpain.2018.12.003_bib0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/03630269509005824","article-title":"The sickle cell painful crisis in adults: Phases and objective signs","volume":"19","author":"Ballas","year":"1995","journal-title":"Hemoglobin"},{"key":"10.1016\/j.jpain.2018.12.003_bib0011","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.hoc.2005.07.008","article-title":"Pain management of sickle cell disease","volume":"19","author":"Ballas","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jpain.2018.12.003_bib0012","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/CH-189003","article-title":"Comorbidities in aging patients with sickle cell disease","volume":"68","author":"Ballas","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.jpain.2018.12.003_bib0013","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ajh.21750","article-title":"Utilization of analgesics in the multicenter study of hydroxyurea in sickle cell anemia: Effect of sex, age, and geographical location","volume":"85","author":"Ballas","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0014","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","article-title":"Sickle cell pain: A critical reappraisal","volume":"120","author":"Ballas","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2018.12.003_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ajh.20336","article-title":"Hospital readmission for adult acute sickle cell painful episodes: Frequency, etiology, and prognostic significance","volume":"79","author":"Ballas","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0016","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jpain.2018.12.003_bib0017","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/1359105314539530","article-title":"The measure of sickle cell stigma: Initial FINDINGS FROM the Improving Patient Outcomes through Respect and Trust study","volume":"21","author":"Bediako","year":"2016","journal-title":"J Health Psychol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0018","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2018.12.003_bib0019","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1172\/JCI26857","article-title":"Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice","volume":"116","author":"Belcher","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpain.2018.12.003_bib0020","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2018.12.003_bib0021","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpain.2016.01.475","article-title":"An evaluation of central sensitization in patients with sickle cell disease","volume":"17","author":"Campbell","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0022","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.amepre.2016.02.012","article-title":"Chronic opioid therapy and central sensitization in sickle cell disease","volume":"51","author":"Carroll","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jpain.2018.12.003_bib0023","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2018.12.003_bib0024","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood-2017-02-769661","article-title":"Genome-wide association study to identify variants associated with acute severe vaso-occlusive pain in sickle cell anemia","volume":"130","author":"Chaturvedi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2018.12.003_bib0025","first-page":"469","article-title":"2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: What are the key messages for clinical practice?","volume":"119","author":"Chou","year":"2009","journal-title":"Polskie Archiwum Medycyny Wewnetrznej"},{"key":"10.1016\/j.jpain.2018.12.003_bib0026","first-page":"14","article-title":"School performance and disease interference in adolescents with sickle cell disease","volume":"34","author":"Crosby","year":"2015","journal-title":"Physical Disabil"},{"key":"10.1016\/j.jpain.2018.12.003_bib0027","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3899\/jrheum.161107","article-title":"Defining flare in osteoarthritis of the hip and knee: A systematic literature review - OMERACT Virtual Special Interest Group","volume":"44","author":"Cross","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0028","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/j.pain.0000000000000914","article-title":"Development and validation of the self-reported PROMIS pediatric pain behavior item bank and short form scale","volume":"158","author":"Cunningham","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0029","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/pbc.25944","article-title":"Initial evaluation of the pediatric PROMIS(R) health domains in children and adolescents with sickle cell disease","volume":"63","author":"Dampier","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpain.2018.12.003_bib0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pbc.24796","article-title":"Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease","volume":"61","author":"Dampier","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpain.2018.12.003_bib0031","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1054\/jpai.2002.128064","article-title":"Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports","volume":"3","author":"Dampier","year":"2002","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0032","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/pbc.20162","article-title":"Physical and cognitive-behavioral activities used in the home management of sickle pain: A daily diary study in children and adolescents","volume":"43","author":"Dampier","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpain.2018.12.003_bib0033","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/pbc.25931","article-title":"Responsiveness of PROMIS(R) pediatric measures to hospitalizations for sickle pain and subsequent recovery","volume":"63","author":"Dampier","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpain.2018.12.003_bib0034","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ajh.21905","article-title":"Health-related quality of life in adults with sickle cell disease (SCD): A report from the comprehensive sickle cell centers clinical trial consortium","volume":"86","author":"Dampier","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0035","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/pbc.22497","article-title":"Health-related quality of life in children with sickle cell disease: A report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium","volume":"55","author":"Dampier","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpain.2018.12.003_bib0036","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpain.2016.12.016","article-title":"AAPT diagnostic criteria for chronic sickle cell disease pain","volume":"18","author":"Dampier","year":"2017","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0037","first-page":"785","article-title":"Vaso-occlusion in children with sickle cell disease: Clinical characteristics and biologic correlates","volume":"26","author":"Dampier","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0038","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jpain.2015.07.005","article-title":"Frequency of hospitalizations for pain and association with altered brain network connectivity in sickle cell disease","volume":"16","author":"Darbari","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0039","article-title":"Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant","author":"Darbari","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0040","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jpeds.2011.07.018","article-title":"Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia","volume":"160","author":"Darbari","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpain.2018.12.003_bib0041","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.sjpain.2017.08.001","article-title":"Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemia","volume":"17","author":"Darbari","year":"2017","journal-title":"Scand J Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01460869509080953","article-title":"Hospitalizations for painful episodes: Association with school absenteeism and academic performance in children and adolescents with sickle cell anemia","volume":"18","author":"Eaton","year":"1995","journal-title":"Issues Compr Pediatr Nurs"},{"key":"10.1016\/j.jpain.2018.12.003_bib0043","first-page":"420","article-title":"Parental substance abuse, reports of chronic pain and coping in adult patients with sickle cell disease","volume":"98","author":"Edwards","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jpain.2018.12.003_bib0044","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/papr.12279","article-title":"Safety and utility of quantitative sensory testing among adults with sickle cell disease: Indicators of neuropathic pain?","volume":"16","author":"Ezenwa","year":"2015","journal-title":"Pain practice: the official journal of World Institute of Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/asheducation-2017.1.406","article-title":"Five lessons learned about long-term pain management in adults with sickle cell disease","volume":"2017","author":"Field","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jpain.2018.12.003_bib0046","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V86.2.776.bloodjournal862776","article-title":"Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease","volume":"86","author":"Gill","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2018.12.003_bib0047","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood-2010-12-327429","article-title":"Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease","volume":"118","author":"Hillery","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2018.12.003_bib0048","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/jpepsy\/jsj076","article-title":"Longitudinal relationships of depressive symptoms to pain intensity and functional disability among children with disease-related pain","volume":"31","author":"Hoff","year":"2006","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0049","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.hoc.2013.11.006","article-title":"Inflammatory mediators of endothelial injury in sickle cell disease","volume":"28","author":"Hoppe","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jpain.2018.12.003_bib0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/s0304-3959(02)00374-3","article-title":"Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease","volume":"102","author":"Jacob","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0051","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pedn.2005.06.002","article-title":"Changes in sleep, food intake, and activity levels during acute painful episodes in children with sickle cell disease","volume":"21","author":"Jacob","year":"2006","journal-title":"J Pediatr Nurs"},{"key":"10.1016\/j.jpain.2018.12.003_bib0052","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI9225","article-title":"Hypoxia\/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice","volume":"106","author":"Kaul","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpain.2018.12.003_bib0053","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10739680802279394","article-title":"Sickle red cell-endothelium interactions","volume":"16","author":"Kaul","year":"2009","journal-title":"Microcirculation"},{"key":"10.1016\/j.jpain.2018.12.003_bib0054","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12955-014-0125-0","article-title":"Patient reports of health outcome for adults living with sickle cell disease: Development and testing of the ASCQ-Me item banks","volume":"12","author":"Keller","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jpain.2018.12.003_bib0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpain.2017.02.421","article-title":"The ACTTION-APS-AAPM Pain Taxonomy (AAAPT) multidimensional approach to classifying acute pain conditions","volume":"18","author":"Kent","year":"2017","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0056","first-page":"896","article-title":"Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathies","volume":"43","author":"Kim","year":"2002","journal-title":"J Nuclear Med"},{"key":"10.1016\/j.jpain.2018.12.003_bib0057","article-title":"Intensive management of high-utilizing adults with sickle cell disease lowers admissions","author":"Koch","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0058","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2010-01-260372","article-title":"Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: Modulation by cannabinoids","volume":"116","author":"Kohli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2018.12.003_bib0059","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ajog.2016.05.032","article-title":"Contemporary outcomes of sickle cell disease in pregnancy","volume":"215","author":"Kuo","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0060","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ajh.21807","article-title":"The burden of emergency department use for sickle-cell disease: An analysis of the national emergency department sample database","volume":"85","author":"Lanzkron","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0061","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.0804799105","article-title":"DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease","volume":"105","author":"Lettre","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpain.2018.12.003_bib0062","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/S0140-6736(15)01341-0","article-title":"Fetal haemoglobin in sickle-cell disease: From genetic epidemiology to new therapeutic strategies","volume":"387","author":"Lettre","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jpain.2018.12.003_bib0063","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/PSY.0b013e31815ff5c5","article-title":"Depression and anxiety in adults with sickle cell disease: The PiSCES project","volume":"70","author":"Levenson","year":"2008","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jpain.2018.12.003_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010659","article-title":"Pathophysiology and therapy for haemoglobinopathies. Part I: Sickle cell disease","volume":"8","author":"Madigan","year":"2006","journal-title":"Exp Rev Mol Med"},{"key":"10.1016\/j.jpain.2018.12.003_bib0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5055\/jom.2017.0382","article-title":"Opioid management strategy decreases admissions in high-utilizing adults with sickle cell disease","volume":"13","author":"Mager","year":"2017","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.jpain.2018.12.003_bib0066","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPH.0b013e3181d869d5","article-title":"Depression, anxiety, and stress comorbidities in sickle cell anemia patients with vaso-occlusive crisis","volume":"32","author":"Mahdi","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0067","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jpain.2016.08.003","article-title":"Disease-related, nondisease-related, and situational catastrophizing in sickle cell disease and its relationship with pain","volume":"17","author":"Mathur","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0068","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/AJP.0000000000000361","article-title":"Multiple levels of suffering: Discrimination in health-care settings is associated with enhanced laboratory pain sensitivity in sickle cell disease","volume":"32","author":"Mathur","year":"2016","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0069","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/jwh.2006.15.146","article-title":"Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES Project","volume":"15","author":"McClish","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jpain.2018.12.003_bib0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1477-7525-3-50","article-title":"Health related quality of life in sickle cell patients: The PiSCES project","volume":"3","author":"McClish","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jpain.2018.12.003_bib0071","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4070547","article-title":"Comorbidity, pain, utilization, and psychosocial outcomes in older versus younger sickle cell adults: The PiSCES Project","volume":"2017","author":"McClish","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jpain.2018.12.003_bib0072","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pmn.2015.09.002","article-title":"Acute pain and depressive symptoms: Independent predictors of insomnia symptoms among adults with sickle cell disease","volume":"17","author":"Moscou-Jackson","year":"2016","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.jpain.2018.12.003_bib0073","first-page":"901","article-title":"Continuing education, clinical competence, and specialty certification","volume":"46","author":"Naftulin","year":"1971","journal-title":"J Med Educ"},{"key":"10.1016\/j.jpain.2018.12.003_bib0074","unstructured":"National Heart, Lung and Blood Institute (NHLBI): Evidence-based management of sickle cell disease: Expert panel report, 2014. Accessed 3\/31\/2017, http:\/\/www.nhlbi.nih.gov\/guidelines"},{"key":"10.1016\/j.jpain.2018.12.003_bib0075","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1590\/S1413-35552012005000043","article-title":"Musculoskeletal pain, profile and quality of life of individuals with sickle cell disease","volume":"16","author":"Ohara","year":"2012","journal-title":"Rev Bras Fisioter"},{"key":"10.1016\/j.jpain.2018.12.003_bib0076","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MLR.0000000000000143","article-title":"National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008","volume":"52","author":"Okam","year":"2014","journal-title":"Med Care"},{"key":"10.1016\/j.jpain.2018.12.003_bib0077","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpain.2008.04.002","article-title":"Daily functioning and quality of life in children with sickle cell disease pain: Relationship with family and neighborhood socioeconomic distress","volume":"9","author":"Palermo","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0078","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/pbc.24491","article-title":"PedsQL sickle cell disease module: Feasibility, reliability, and validity","volume":"60","author":"Panepinto","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpain.2018.12.003_bib0079","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pbc.24776","article-title":"PedsQL Multidimensional Fatigue Scale in sickle cell disease: Feasibility, reliability, and validity","volume":"61","author":"Panepinto","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpain.2018.12.003_bib0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2018.12.003_bib0081","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2018.12.003_bib0082","first-page":"755","article-title":"Sleep-disordered breathing in patients with sickle cell disease","volume":"97","author":"Raghunathan","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0083","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/pbc.21781","article-title":"Healthcare utilization and expenditures for low income children with sickle cell disease","volume":"52","author":"Raphael","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpain.2018.12.003_bib0084","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/bmj.1.6001.66","article-title":"Climate and painful crisis of sickle-cell disease in Jamaica","volume":"1","author":"Redwood","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.jpain.2018.12.003_bib0085","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jpain.2018.12.003_bib0086","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-3476(05)82156-0","article-title":"Cold water exposure and vaso-occlusive crises in sickle cell anemia","volume":"118","author":"Resar","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpain.2018.12.003_bib0087","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ogc.2010.02.015","article-title":"Sickle cell disease in pregnancy","volume":"37","author":"Rogers","year":"2010","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.jpain.2018.12.003_bib0088","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jpepsy\/jss051","article-title":"Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease","volume":"37","author":"Schlenz","year":"2012","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0089","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pain.2009.07.008","article-title":"Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea","volume":"146","author":"Smith","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1524-9042(02)54211-9","article-title":"Temperature changes, temperature extremes, and their relationship to emergency department visits and hospitalizations for sickle cell crisis","volume":"4","author":"Smith","year":"2003","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.jpain.2018.12.003_bib0091","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5055\/jom.2015.0273","article-title":"Daily home opioid use in adults with sickle cell disease: The PiSCES project","volume":"11","author":"Smith","year":"2015","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.jpain.2018.12.003_bib0092","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpain.2018.12.003_bib0093","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/asheducation-2010.1.409","article-title":"Sickle-cell pain: Advances in epidemiology and etiology","volume":"2010","author":"Smith","year":"2010","journal-title":"Hematol Am Soc Hemat Educ Program"},{"key":"10.1016\/j.jpain.2018.12.003_bib0094","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.psym.2011.01.010","article-title":"Somatic symptom burden in adults with sickle cell disease predicts pain, depression, anxiety, health care utilization, and quality of life: The PiSCES project","volume":"52","author":"Sogutlu","year":"2011","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpain.2018.12.003_bib0095","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1097\/j.pain.0000000000001009","article-title":"Defining chronic pain in epidemiological studies: A systematic review and meta-analysis","volume":"158","author":"Steingrimsdottir","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0096","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/bju.12778","article-title":"Urological chronic pelvic pain syndrome symptom flares: Characterisation of the full range of flares at two sites in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network","volume":"114","author":"Sutcliffe","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.jpain.2018.12.003_bib0097","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood-2015-09-618553","article-title":"Beyond hydroxyurea: New and old drugs in the pipeline for sickle cell disease","volume":"127","author":"Telen","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2018.12.003_bib0098","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/asheducation-2017.1.546","article-title":"Targeting novel mechanisms of pain in sickle cell disease","volume":"2017","author":"Tran","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jpain.2018.12.003_bib0099","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/1359105312471570","article-title":"Psychological aspects and hospitalization for pain crises in youth with sickle-cell disease","volume":"19","author":"Tsao","year":"2014","journal-title":"J Health Psychol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0100","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.052522799","article-title":"Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm","volume":"99","author":"Turhan","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpain.2018.12.003_bib0101","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/08880018.2010.540735","article-title":"Evaluation of the psychological problems in children with sickle cell anemia and their families","volume":"28","author":"Unal","year":"2011","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0102","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2018.12.003_bib0103","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","article-title":"Mast cell activation contributes to sickle cell pathobiology and pain in mice","volume":"122","author":"Vincent","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2018.12.003_bib0104","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jpepsy\/15.5.643","article-title":"Pain in children and adolescents with sickle cell disease: A descriptive study","volume":"15","author":"Walco","year":"1990","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0105","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2009-02-205492","article-title":"NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines","volume":"114","author":"Wallace","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2018.12.003_bib0106","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: A multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jpain.2018.12.003_bib0107","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/asheducation-2010.1.403","article-title":"Neurobiological mechanisms of pain in sickle cell disease","volume":"2010","author":"Wang","year":"2010","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jpain.2018.12.003_bib0108","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<183::AID-AJH2>3.0.CO;2-S","article-title":"Assessment of painful episode frequency in sickle-cell disease","volume":"54","author":"Westerman","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpain.2018.12.003_bib0109","doi-asserted-by":"crossref","unstructured":"Wilkie DJ, Molokie R, Boyd-Seal D, Suarez ML, Kim YO, Zong S, Wittert H, Zhao Z, Saunthararajah Y, Wang ZJ: Patient-reported outcomes: Descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. J Natl Med Assoc 102:18-27","DOI":"10.1016\/S0027-9684(15)30471-5"},{"key":"10.1016\/j.jpain.2018.12.003_bib0110","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: Implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0111","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/pbc.21572","article-title":"Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease","volume":"51","author":"Zempsky","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpain.2018.12.003_bib0112","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jpain.2014.09.008","article-title":"Development and validation of the Youth Acute Pain Functional Ability Questionnaire (YAPFAQ)","volume":"15","author":"Zempsky","year":"2014","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0113","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/AJP.0000000000000492","article-title":"Altered Functional Connectivity in Sickle Cell Disease Exists at Rest and During Acute Pain Challenge","volume":"33","author":"Zempsky","year":"2017","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2018.12.003_bib0114","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590018310174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590018310174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:01:31Z","timestamp":1761508891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590018310174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":114,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1526590018310174"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2018.12.003","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAAPT Diagnostic Criteria for Acute Sickle Cell Disease Pain","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2018.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Pain Society","name":"copyright","label":"Copyright"}]}}